Announced Fri, 27 Mar · 22:24 IST

This is in continuation to the meetings of the Board of Directors ( Board ) of HealthCare Global Enterprises Limited ( Company ) held on February 17, 2026, approving the offer and issue of equity shares of the Company ( Equity Shares ) on a rights basis to eligible equity shareholders of the Company ( Issue ) and our intimation dated February 24, 2026, regarding the outcome of the meeting of the Board held on February 24, 2026, approving the various terms of the Issue and the meeting of the Board held on February 24, 2026, approving the Letter of Offer.In relation to the aforesaid Issue, opened on March 11, 2026 and closed on March 25, 2026, and pursuant to the finalization of the basis of allotment of the Issue, in consultation with the Kfin Technologies Limited and ( Registrar to the Issue ) and as approved by the designated stock exchange, National Stock Exchange of India Limited, the Rights Issue Committee at its meeting held today, i.e., March 27, 2026, inter alia, considered and approved the allotment of 82,94,566 Equity Shares of Face Value of Rs. 10 each on Rights Basis to the eligible shareholders and/ or renouncee(s) in terms of the Letter of Offer at a price of Rs. 512 per Equity Share (including a premium of Rs. 502 per Equity Share) ( Allotment ).

Fund Raising View source PDF

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹530.00
prior close
₹528.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.2+0.1-0.4+0.2-0.4+2.0+0.8+4.9+4.9+7.1+8.8+21.9+18.6
Up moveDown movePending
AI summary

HealthCare Global Enterprises (HCG) has completed its rights issue, allotting 82,94,566 equity shares at Rs. 512 per share (face value Rs. 10, premium Rs. 502) to eligible shareholders. The rights issue opened on March 11, 2026 and closed on March 25, 2026, with the record date being March 2, 2026. The total issue size works out to roughly Rs. 424.7 crore. As a result, the company's paid-up equity share capital has increased from Rs. 141.01 crore (14,10,07,637 shares) to Rs. 149.30 crore (14,93,02,203 shares), a dilution of about 5.9% for non-subscribing shareholders. The allotment was approved by the Rights Issue Committee on March 27, 2026, in consultation with registrar Kfin Technologies and NSE.

Likely market impact

Existing shareholders who did not subscribe to the rights issue will see their stake diluted by around 5.9%. The successful completion of the Rs. 424.7 crore fundraise strengthens the company's balance sheet and may support its growth and expansion plans, though the specific use of proceeds is not disclosed in this filing.